| Aug 20 |
Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology
|
| Aug 19 |
Genetic testing in Parkinson’s disease patients: a standard of care imperative?
|
| Aug 14 |
Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Int...
|
| Aug 6 |
Wall Street Analysts Believe Denali Therapeutics (DNLI) Could Rally 79.62%: Here's is How to Trade
|
| Aug 1 |
Denali Therapeutics GAAP EPS of -$0.59 beats by $0.11
|
| Aug 1 |
Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
|
| Jul 23 |
Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
|
| Jul 16 |
Denali Therapeutics Stock Gets Technical Rating Upgrade
|
| Jul 8 |
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
|
| Jun 28 |
Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
|
